A cDNA clone encoding the mRNA for the highly polymorphic human enzyme phosphoglucomutase 1 (PGM1; EC 5.4.2.2) has been isolated and characterized. This was achieved indirectly by first isolating a rabbit cDNA from an expression library using anti-rabbit PGM antibodies. A comparison of the nucleotide sequences shows that the homologies between human and rabbit PGM1 mRNAs are 92% and 97% for the coding nucleotide sequence and the amino acid sequence, respectively. The derived rabbit amino acid sequence is in complete agreement with the published protein sequence for rabbit muscle PGM. A physical localization of the human PGMI gene to chromosome lp3l has been determined by in situ hybridization. Analysis of DNA from a wide variety of vertebrates indicates a high level of PGMI sequence conservation during evolution.
Phosphoglucomutase (PGM; EC 5.4.2.2) catalyzes the interconversion of glucose 1-phosphate and glucose 6-phosphate and thus has a pivotal role in glycolysis and gluconeogenesis. The human enzyme is encoded by three autosomal unlinked structural loci, designated PGMJ, PGM2, and PGM3 (1, 2), and there is evidence for a fourth locus expressed in human milk (3) . On the basis of protein studies, it is assumed that the loci arose by gene duplication and evolved separately to provide the present day isozymes, showing distinctive properties, such as molecular size (4), thermostability (5), substrate specificity (6) , tissue distribution (7) , and sulfhydryl group reactivity (8) . Multiple isozymes, attributable to multiple PGM loci have been identified in a very wide range of species and it is evident that the initial PGM gene duplication(s) occurred in the remote evolutionary past.
Isozyme polymorphism of human PGMI was identified more than 25 years ago (9) and the locus has since been shown to exhibit a very high incidence of both common and rare allelic variation in all populations (10) . The PGMI locus is an important anchor point for linkage analysis and for positioning markers on human chromosome lp and its homologues in other species. The heterozygosity demonstrable by isozyme analysis of human erythrocytes [0.81 in the Centre d'Etude Polymorphisme Humain (CEPH) family panel for example] is comparable to several of the variable number tandem repeat loci and exceeds most of the restriction fragment length polymorphisms recognized by other probes on chromosome 1 . The PGM1 isozyme polymorphism is a particularly useful marker of individuality in forensic science (11, 12) since the discriminating power of the PGMI locus (1 -probability of a match) is about 0.75 for the common isozyme phenotypes revealed by isoelectric focusing (12) . Furthermore, the isozymes are found in a variety of body fluids and enzyme activity is retained for prolonged periods in stains recovered from scenes of crimes.
The extensive heterozygosity of PGMJ and certain features of the variant isozyme patterns have led to speculation about the role of intragenic recombination in generating this diversity. The isozymes associated with the two alleles, PGMJ*1 and PGMI*2, discovered by starch gel electrophoresis, can be subdivided by isoelectric focusing into two classes: one designated "+" is more anodal than the other, designated "-". Thus four alleles (PGMI*J+, 1, 2+, and 2-) define 10 common phenotypes (11) . Furthermore, the properties of these common alleles 1 vs. 2 and + vs. -do not occur in a random association. Similarly, the isozymes encoded by the less-common PGM alleles PGMI*3 and PGMI*7 can also be subdivided by isoelectric focusing into + and -categories and here also the association of the latter property with the electromorphs (PGM1*3 vs. PGM1*7) is not random (13) . These findings have led to the suggestion that much of the PGM1 diversity might be attributed to intragenic recombination. A gene phylogeny has been constructed for the eight most common alleles, in which intragenic recombination plays at least as significant a role as nucleotide substitution in the generation of allelic diversity (13) .
In the present communication, we describe the isolation and the full sequence of both human and rabbit PGM1 mRNA. Antibodies raised in a sheep against purified rabbit muscle PGM cross react with human PGM1 (14) but are not sufficiently sensitive to detect human PGM1 expressed in phage expression vectors. Thus we approached the cloning of human PGM1 by using the antibodies to isolate a rabbit PGM1 cDNA clone, which was then employed as a human library screening probe. The cloning of the human PGM1 cDNAt will allow the hypothesis of the origin of the allelic diversity to be fully tested.
MATERIALS AND METHODS
Cloning of Human and Rabbit PGMI. Poly(A)+ RNA was isolated from rabbit hind leg muscle by selective LiCl precipitation and binding to oligo(dT)-cellulose. A cDNA library (2 x 106 recombinants) was produced in the expression vector Agtll using standard procedures with EcoRI adapters (15) and screened using antibodies raised in a sheep and specific for rabbit muscle PGM1 (14) . Positive plaques were recloned three times to yield plaque-purified phage. cDNA inserts were removed by EcoRI digestion, gel-purified, and used to screen a human muscle cDNA library (15) . The human PGM1 recombinants were similarly plaque-purified.
Abbreviations: PGM, phosphoglucomutase; CEPH, Centre d'Etude Polymorphisme Humain. tThe sequence reported in this paper has been deposited in the GenBank data base (accession no. M83088).
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Large-scale preparations of purified A recombinants were carried out using a standard cesium chloride centrifugation procedure (16) .
Subcloning and Labeling of cDNA Probes. Both human and rabbit cDNA inserts were subcloned into EcoRI sites of pUC18 and M13mp18 vectors. Preparations of plasmid or the replicative form of M13 were purified by equilibrium centrifugation in cesium chloride (16) . cDNA inserts from pUC18 recombinants were gel-purified and labeled with 32p using the oligonucleotide primer method (17 In Situ Hybridization. In situ hybridization was carried out on spreads of human metaphase chromosomes by using a biotinylated whole PGM1 cosmid as probe as described (20) but with certain modifications. Human Cot, DNA, a fraction of total DNA in which highly repetitive sequences are prevalent, was used at a 50-fold excess of probe concentration to suppress hybridization to these sequences. Signal detection was achieved using fluorescein isothiocyanate-conjugated avidin and amplified by alternate applications of biotinylated anti-avidin and fluorescein isothiocyanate-conjugated avidin. Preparations were mounted in anti-fade solution p-phenylenediamine dihydrochloride to which the fluorochromes diamidinophenylindole and propidium iodide had been added for counterstaining and banding. Preparations were evaluated using epifluorescence microscopy. Separate images were obtained for each fluorochrome, collected electronically by laser scanning (Bio-Rad MRC 600 confocal microscope), and merged. Signal position was compared with R-banding patterns for at least 10 metaphases showing signal on both chromatids with negligible background.
PCR Analysis of Somatic Cell Hybrids. Details of the somatic cell hybrids used are listed either in Carritt et al. (21) or Wong et al. (22) . Hybrid DNA or human or rodent parent DNA (3 /Lg) was amplified using 25-mer oligonucleotides from the 3' untranslated region of human PGMI (see Fig. 1 (25, 26) but their general significance is not known.
A Southern blot analysis of DNA from animal species indicates that PGMJ is conserved among a wide variety of vertebrates ranging from primates to birds and amphibia (Fig.   3 ).
PGM1 on Human Chromosome 1. Human PGMJ was assigned to chromosome 1 by isozyme analysis in rodenthuman somatic cell hybrids (27) and the regional localization has been refined by linkage analysis to 1p22 (28) . PCR analysis using primer oligonucleotides from the 3' untranslated region of the PGM1 cDNA confirms the assignment to ip. Fig. 4 Upper shows the amplification of DNA from two hybrids, CRAB5 and CRAB4, which differ only by the presence of human chromosomes 1 and 3 in CRAB5 and their absence in CRAB4. Also shown are amplifications of DNA from TWIN19F9 and TWIN19F6, which differ only by the absence of chromosome 1 from TWIN19F6. (CRAB11, which is also shown in Fig. 4 , is negative for chromosome 1 markers.) Fig. 4 also includes two hybrids HCH5 and HCH7 (20) , which contain the reciprocal halves of the translocation t(1;10)(p36.31;q22.1). HCH7, which contains lp36.1 to lqter, is positive for the PGMI-amplified product whereas its counterpart HCHS (lp36.1 to lpter) is negative. signal and the terminus to the centromere were measured and expressed as a proportion in each case and gave a value of 0.52 (n = 20, SD = 0.04). This indicated a location for the PGMI gene of lp3l.
DISCUSSION
The PGM1 protein is highly polymorphic in humans and an investigation of genetic variation at the nucleotide level should provide detailed information on the evolution of this variation. We are particularly interested to test the hypothesis of Carter et al. (11) developed in detail by Takahashi al. (13) , which proposed that reciprocal intragenic recombination between existing amino acid substitutions has been a major mechanism in the generation of structural allelic variants ofPGMJ detected by isoelectric focusing. The isolation of the complete human PGM1 cDNA sequence enables the analysis of haplotypes in genomic DNA and the identification of candidate sites of recombination. Our preliminary analysis suggests the total size of the PGMI gene does not exceed 34 kilobases and thus any tendency for high recombination frequency would seem to be a specific property of the PGMI sequence rather than a result of large target size. Interestingly, interspecific comparisons indicate less variability than might be expected if this ancient gene were highly mutable. The homology between human and rabbit PGM1 is 92% at the nucleotide level and 97% at the derived amino acid level; furthermore, a high level of sequence conservation appears to be retained throughout the vertebrate kingdom. It is noteworthy that the signal intensity from Southern blot analysis of tree-frog DNA equaled that of the orangutan and marmoset after hybridization at moderate stringency. Such sequence conservation is compatible with the view that the human PGM1 polymorphism has arisen by mechanisms other than the straightforward accumulation ofpoint mutations (11, 13) .
A computer-based comparison of the human PGM1 amino acid sequence with those of the human muscle-specific phosphoglycerate mutase PGAM2 (29) and diphosphoglycerate mutase DPGAM (30) revealed no homologies. This is in line with the finding ofRay et al. (23) that there are no obvious similarities between the protein sequences of rabbit muscle PGM and yeast phosphoglycerate mutase (PGAM) .
No evidence for PGM1-related sequences was found either by Southern blot analysis of human genomic DNA or by in situ hybridization. Thus if the genes encoding human PGM2 and PGM3, assigned to chromosomes 4 and 6, respectively (2), arose by duplication from the same ancestral gene as PGMJ, then it seems likely that less than 65% sequence homology has been preserved. Immunological data support this view; the anti-rabbit PGM1 antibodies recognize all of the human PGM1 isozymes but not those encoded by PGM2 and PGM3 (31) and no cross reactivity between human PGM1 and PGM2 using anti-human reagents has been demonstrated (32) . Thus it may not be possible to identify cDNAs for PGM2 and PGM3 using PGM1 cDNA as a probe, but it is hoped that an oligonucleotide encoding the active site region will be a useful tool for this purpose.
Cloning the human PGMJ gene has allowed the direct chromosomal localization of this locus and this has resolved some uncertainty about the exact position of this widely used genetic marker. A position for PGMI of lp22 is generally accepted, although a more distal location has not been excluded (28) . In the recent CEPH consortium linkage map of human chromosome 1, assembled by multipoint analysis of 58 loci, PGMJ is positioned distal to the markers D1S22 and ACADM and proximal to D1S19 (33) . Pakstis et al. (34) using linkage analysis in seven non-CEPH pedigrees, reported essentially the same order but argued that since the SRO (shortest region of overlap) for D1S19 is lpter-p31 and for ACADM is 1p31 then PGMJ cannot be in 1p22 but rather must be in 1p31 (or more distal). Our results support this view and indicate a localization of 1p31.
